C5aR pepducins (Anchor Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameC5aR pepducins (Anchor Therapeutics)
Drug Alias Namecomponent 5a receptor modulators (Anchor Therapeutics)
ClassificationBiologics
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor modulators
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnchor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnchor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A